title: Intravenous administration of N-acetylcysteine: oral and parenteral formulations are both acceptable.
authors.forename: Eric J
authors.initials: EJ
authors.lastname: Lavonas
authors.forename: Michael C
authors.initials: MC
authors.lastname: Beuhler
authors.forename: Marsha D
authors.initials: MD
authors.lastname: Ford
authors.forename: William P
authors.initials: WP
authors.lastname: Kerns
authors.forename: Anna M
authors.initials: AM
authors.lastname: Rouse
authors.forename: Christian A
authors.initials: CA
authors.lastname: Tomaszewski
authors.forename: Mary A
authors.initials: MA
authors.lastname: Wittler
mesh_terms: D000082:Acetaminophen / Q000506:poisoning*; D000111:Acetylcysteine / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics; D004304:Dosage Forms; D006801:Humans; D007275:Injections, Intravenous
chemical_list: D004304:Dosage Forms; D000082:Acetaminophen; D000111:Acetylcysteine